Doesn't sound like it will get up... (if it does it may be an adjunct treatment)
Also 1 injection, but a more painful one.
Also we wouldn't have to go back to our doc as it will be self administered (prob a pen)
Also if our results are better, we would be a first line treatment, not them.
Also there is room for more than one drug anyway.
Also based on our phase 2 our results are better and much more likely to be DMOAD so we are most likely still to be first in line treatment.
Also if we end up second inline treatment for some reason, the market is so big that we would still be trading at many tens of multiples from here.
Also dont forget we have other indications as well such as MPS and others.
Lorecivivint, page-19
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
-0.005(1.96%) |
Mkt cap ! $87.44M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 25.0¢ | $13.08K | 51.83K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 133489 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 25012 | 2 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |